» Articles » PMID: 34233060

Early Diagnosis of Amyotrophic Lateral Sclerosis by Threshold Tracking and Conventional Transcranial Magnetic Stimulation

Overview
Journal Eur J Neurol
Publisher Wiley
Specialty Neurology
Date 2021 Jul 7
PMID 34233060
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Short-interval intracortical inhibition by threshold tracking (T-SICI) has been proposed as a diagnostic tool for amyotrophic lateral sclerosis (ALS) but has not been compared directly with conventional amplitude measurements (A-SICI). This study compared A-SICI and T-SICI for sensitivity and clinical usefulness as biomarkers for ALS.

Methods: In all, 104 consecutive patients referred with suspicion of ALS were prospectively included and were subsequently divided into 62 patients with motor neuron disease (MND) and 42 patient controls (ALS mimics) by clinical follow-up. T-SICI and A-SICI recorded in the first dorsal interosseus muscle (index test) were compared with recordings from 53 age-matched healthy controls. The reference standard was the Awaji criteria. Clinical scorings, conventional nerve conduction studies and electromyography were also performed on the patients.

Results: Motor neuron disease patients had significantly reduced T-SICI and A-SICI compared with the healthy and patient control groups, which were similar. Sensitivity and specificity for discriminating MND patients from patient controls were high (areas under the receiver operating characteristic curves 0.762 and 0.810 for T-SICI and A-SICI respectively at 1-3.5 ms). Paradoxically, T-SICI was most reduced in MND patients with the fewest upper motor neuron (UMN) signs (Spearman ρ = 0.565, p = 4.3 × 10 ).

Conclusions: Amplitude-based measure of cortical inhibition and T-SICI are both sensitive measures for the detection of cortical involvement in MND patients and may help early diagnosis of ALS, with T-SICI most abnormal before UMN signs have developed. The gradation in T-SICI from pathological facilitation in patients with minimal UMN signs to inhibition in those with the most UMN signs may be due to progressive degeneration of the subset of UMNs experiencing facilitation.

Citing Articles

Detailed Analysis of the Palmomental Reflex and Its Clinical Significance.

Ma B, Zhang J, Cui Y, Gao H Brain Behav. 2024; 14(11):e70164.

PMID: 39576271 PMC: 11583821. DOI: 10.1002/brb3.70164.


Instrumented assessment of lower and upper motor neuron signs in amyotrophic lateral sclerosis using robotic manipulation: an explorative study.

Stikvoort Garcia D, Sleutjes B, Mugge W, Plouvier J, Goedee H, Schouten A J Neuroeng Rehabil. 2024; 21(1):193.

PMID: 39472924 PMC: 11520903. DOI: 10.1186/s12984-024-01485-9.


Physiological Biomarkers of Upper Motor Neuron Dysfunction in ALS.

Calma A, van den Bos M, Pavey N, Santos Silva C, Menon P, Vucic S Brain Sci. 2024; 14(8).

PMID: 39199454 PMC: 11352893. DOI: 10.3390/brainsci14080760.


Threshold tracking transcranial magnetic stimulation and neurofilament light chain as diagnostic aids in ALS.

Jacobsen A, Bostock H, Howells J, Cengiz B, Samusyte G, Koltzenburg M Ann Clin Transl Neurol. 2024; 11(7):1887-1896.

PMID: 38894662 PMC: 11251469. DOI: 10.1002/acn3.52095.


Examining short interval intracortical inhibition with different transcranial magnetic stimulation-induced current directions in ALS.

McMackin R, Tadjine Y, Fasano A, Mitchell M, Heverin M, Awiszus F Clin Neurophysiol Pract. 2024; 9:120-129.

PMID: 38595691 PMC: 11002888. DOI: 10.1016/j.cnp.2024.03.001.


References
1.
Tankisi H, Nielsen C, Howells J, Cengiz B, Samusyte G, Koltzenburg M . Early diagnosis of amyotrophic lateral sclerosis by threshold tracking and conventional transcranial magnetic stimulation. Eur J Neurol. 2021; 28(9):3030-3039. PMC: 9291110. DOI: 10.1111/ene.15010. View

2.
Vucic S, Kiernan M . Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease. Neurotherapeutics. 2016; 14(1):91-106. PMC: 5233629. DOI: 10.1007/s13311-016-0487-6. View

3.
Di Lazzaro V, Oliviero A, Profice P, Ferrara L, Saturno E, Pilato F . The diagnostic value of motor evoked potentials. Clin Neurophysiol. 1999; 110(7):1297-307. DOI: 10.1016/s1388-2457(99)00060-7. View

4.
Mejzini R, Flynn L, Pitout I, Fletcher S, Wilton S, Akkari P . ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?. Front Neurosci. 2019; 13:1310. PMC: 6909825. DOI: 10.3389/fnins.2019.01310. View

5.
Masrori P, Van Damme P . Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020; 27(10):1918-1929. PMC: 7540334. DOI: 10.1111/ene.14393. View